This devastating manifestation of syphilis infection can result in blindness if not detected and treated early. CDC Expert Commentary
Author: Medscape
Glaucoma and Cataract Surgery: Two Roads Merging Into One
In this review, the benefits and challenges of cataract surgery for managing coexisting glaucoma and cataracts are discussed. Current Opinion in Ophthalmology
Blue Light From Screens, Bulbs Won’t Damage Retina
Despite concerns that staring at devices putting out high amounts of the blue light wavelength could damage human retinas, a recent study finds that most devices put out less of that light than the blue sky on a clear day. Reuters Health Information
Anti-VEGF Therapy for Persistent Diabetic Macular Edema
In patients with persistent diabetic macular edema (DME), there may be long-term benefits to be gained from continuing with anti-vascular endothelial growth factor (anti-VEGF) therapy, according to a post hoc analysis of a Diabetic Retinopathy Clinical…
Current Therapeutic Developments in Atrophic AMD
More effective therapies are on the horizon for atrophic AMD. Find out what’s new. The British Journal of Ophthalmology
Intraocular Lens Pipeline Yields Increasing Options
In addition to existing premium lenses, each with unique advantages and disadvantages, ophthalmologists will soon have access to even more promising technologies for treating presbyopia. Medscape Ophthalmology
Ranibizumab Treat-and-Extend Regimen May Be Better for Neovascular AMD
A ranibizumab treat-and-extend regimen appears to be better than a pro re nata (PRN) regimen for treating neovascular age-related macular degeneration (AMD), according to researchers from Switzerland. Reuters Health Information
Refractive Outcomes Stable at Five Years After SMILE Procedure for Myopia
Refractive outcomes remain stable at five years in the first eyes treated with small incision lenticule extraction (ReLEx SMILE, Zeiss) for myopia, report ophthalmologists from Germany. Reuters Health Information
Phaco Surgery Poised to Enter a More Virtual Future
Increasing demand has created a groundswell of innovation, ranging from 3D surgical interfaces to remote technology that can place ophthalmologists half a world away from their patients. Medscape Ophthalmology
Bevacizumab for ROP May Trigger Hypotension in Preemies
Intravitreal bevacizumab therapy for retinopathy of prematurity should be used with caution, as it might lead to hypotension in premature infants, a recent case study showed. Medscape Medical News
Dry Eye Syndrome: Diagnostic and Treatment Tips
An overview of established and emerging knowledge on dry eye syndrome aims to give clinicians the tools for effectively managing this disruptive condition. Medscape Ophthalmology
Dry Eye and Depression
Is there a relationship between dry eye and depression; and, if so, which came first? A new study attempts to answer these questions. Medscape Ophthalmology
A Biomarker for Multiple-System Atrophy?
Retinal changes on high-definition optical coherence tomography may help differentiate multiple-system atrophy from Parkinson’s disease, a new study suggests. Medscape Medical News
Is Cataract Surgery Safe for Patients With Wet AMD?
Does cataract surgery contribute to the progression of wet age-related macular degeneration? Medscape Ophthalmology
Antithyroid Treatment as Effective as RAI for Graves Relapse
Low-dose methimazole treatment is an option for relapsed Grave’s disease patients and even showed greater improvement in Graves’ ophthalmopathy compared with radioiodine treatment. Medscape Medical News
Dietary Nitrate in Vegetables May Protect Against Glaucoma
Benefits were seen with 1.45 servings of leafy greens per day. Medscape Medical News
Changing Medical Education With 3D Printing
Are the days of smelling formaldehyde in a cold anatomy lab behind us? Medscape Optometry
Surgical Options for the Correction of Presbyopia
This review examines the benefits and drawbacks of various strategies for the surgical correction of presbyopia. The British Journal of Ophthalmology
No Long-Term Benefit From Intravitreal Bevacizumab in Neovascular Glaucoma: Study
Intravitreal bevacizumab does not alter the long-term outcomes of neovascular glaucoma (NVG), so panretinal photocoagulation (PRP) should remain the mainstay of treatment, according to a retrospective study. Reuters Health Information
The Best of Retina
From anti-VEGF agents to emerging therapies for proliferative vitreoretinopathy, some of the best presentations in retina from this year’s American Academy of Ophthalmology meeting are reviewed. Medscape Ophthalmology